Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants

Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: محمدباقر حسینی , کیوان میرنیا , مرتضی قوجازاده , مهین سید حجازی , بابک اهرچی فرشی

کلمات کلیدی: Keywords Preterm infants, endotracheal intubation, Fentanyl, Remifentanil, Premature Infant Pain Profle – Revised, surfactant.

نشریه: 0 , 2018;7(2):e070214 , 2018;7(2):e070214 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بابک اهرچی فرشی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 63638
عنوان فارسی مقاله Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants
عنوان لاتین مقاله Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق) Journal of Pediatric and Neonatal Individualized Medicine
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Abstract Introduction: Today, the reality of pain in neonates is an undisputed fact, but pain management in clinical practice remains a challenging issue. All neonatal units should have a pain management protocol. The aim of this study was to compare the effectiveness of Remifentanil versus Fentanyl in pain control during elective endotracheal intubation for surfactant administration in preterm infants. Materials and methods: Preterm infants with gestational age between 28 weeks and 34 weeks + 6 days with Respiratory Distress Syndrome (RDS) who needed surfactant administration were divided into two groups using a random sampling method. Neonates in the frst group received 2 μg/kg intravenous Fentanyl infusion and neonates in group 2 received 1 μg/kg intravenous Remifentanil before elective endotracheal intubation for surfactant therapy. The vital signs, including heart rate, oxygen saturation, mean arterial blood pressure and change in facial grimace were documented in an unnamed Premature Infant Pain Profle-Revised (PIPP-R) scoring sheet individually. Video recording was performed in both groups before, during and after the endotracheal intubation. All videos and data were interpreted and scored by two Newborn Individualized Developmental Care and Assessment Program (NIDCAP) professionals. Results: The mean PIPP-R score in the Fentanyl-treated group was 13.06 ± 3.55 and in the Remifentanil-treated group was 10.75 ± 2.93, with no statistically signifcant difference (p = 0.054). There was less need for Naloxone use in the Remifentanil group (p < 0.001). Incidence of apnea, severe drop in oxygen saturation, IntraVentricular Hemorrhage (IVH) and chest rigidity were not signifcantly different between the two groups. Conclusion: Although the difference was not statistically signifcant, Remifentanil reduced the pain score more than Fentanyl during elective endotracheal intubation in preterm infants. We recommend conducting further studies with larger study populations to determine the better drug and the optimal dosage of these drugs in neonates.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
محمدباقر حسینیاول
کیوان میرنیادوم
مرتضی قوجازادهسوم
مهین سید حجازیچهارم
بابک اهرچی فرشیپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Remifentanil versus Fentanyl for pain control during elective endotracheal intubation for surfactant administration in preterm infants.pdf1397/05/201305145دانلود